Blood marker study to predict severe bacterial lung infection
Part of Heart & circulation, Infections, Lungs & breathing clinical trials.
This study looks at specific immune cells and how fats are transported in the blood to predict which people will have a severe bacterial infection (like pneumonia or sepsis). Your results may help doctors identify higher-risk patients earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a severe bacterial lung infection from the community (pneumonia) and/or sepsis.
- Your infection is considered severe based on common medical scoring (SOFA score above 2).
- You can follow all study instructions and complete required study tests.
- You can give informed consent (or have it provided appropriately).
- You have not had certain key health conditions or medicines that could affect results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks if certain blood markers (CRP, CRP/albumin ratio, and neutrophil/lymphocyte ratio) can predict how well sepsis patients with normal blood pressure will do. It aims to help doctors better manage infections and survival.
This study looks at blood test “markers” to tell the difference between infection and non-infectious illness. It may help doctors recognize infection earlier and avoid confusion with other conditions.
This trial looks at patterns in certain immune cells (neutrophils) in people with sepsis in the ICU, including those who have a breathing tube. It may help doctors better understand how the immune system changes during sepsis and could guide future care.
This study looks at blood and other lab test results (“biomarkers”) to better predict what may happen to people with infective endocarditis, a serious infection of the heart lining or heart valves. Your information may help doctors estimate risk and choose care more safely and effectively.
This study is testing a new tool to predict how well people with pneumonia or sepsis will recover. If you have either infection and are 18 or older, you may be able to join.
This study tests a new blood test (Microbio InfectID-BSI) to see how well it detects bacteria and yeast in patients with a possible bloodstream infection. If you are already having a blood culture done, the study will collect extra blood samples at the same time to compare the new test's results.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.